The patient is a 45-year-old male who is scheduled to undergo surgery. His medical history includes hypertension, hyperlipidemia, and type 2 diabetes mellitus, which have been well-controlled with medication. He has been taking lisinopril for his hypertension, atorvastatin for hyperlipidemia, and metformin for diabetes. 

The patient has a history of smoking but quit five years ago. He denies any significant respiratory symptoms or history of lung disease. He has no known drug allergies and has had no previous surgeries.

His past medical history also includes a myocardial infarction five years ago, which was successfully managed with percutaneous coronary intervention (PCI) and stent placement. He has been adherent to his dual antiplatelet therapy with aspirin and clopidogrel since then.

In terms of family history, his father had a history of coronary artery disease and underwent coronary bypass surgery. 

Preoperatively, the patient had a thorough evaluation by the anesthesia team and was found to be at moderate risk for surgery due to his history of coronary artery disease. His functional capacity and exercise tolerance were assessed as good.

He is a non-obese patient with a body mass index (BMI) of 26. 

Laboratory investigations including complete blood count, comprehensive metabolic panel, coagulation profile, and cardiac enzymes were within normal limits. His renal function, assessed by serum creatinine, is currently within the normal range.

The patient was advised to continue his regular medications until the day of surgery, with instructions to hold his dual antiplatelet therapy for a week prior to the procedure under the guidance of his cardiologist.

On the day of surgery, the patient was brought to the operating room and underwent successful general anesthesia without any complications.

The surgical procedure was performed without any intraoperative complications. The patient received appropriate intraoperative fluid management and antibiotic prophylaxis.

Postoperatively, the patient was closely monitored in the recovery room for a few hours to ensure hemodynamic stability. He was transferred to the surgical ward in stable condition.

The patient was started on prophylactic low-molecular-weight heparin for deep vein thrombosis prevention and was encouraged to ambulate early.

Pain management was achieved with a multimodal approach including non-opioid analgesics and patient-controlled analgesia as needed.

The patient had an uneventful postoperative course with no signs of surgical site infection or wound complications.

He was closely monitored for any signs of postoperative complications such as respiratory distress, chest pain, or signs of infection.

His vital signs remained stable, and his laboratory values, including renal function, were monitored and within normal limits.

The patient was able to tolerate a regular diet and his blood glucose levels were well-controlled during his hospital stay.

He continued his regular medications, and a follow-up appointment was scheduled with his primary care physician one week after discharge.

Overall, the patient had a successful surgery and an uneventful postoperative course without any complications.